Svoronos Dawn
- SEC CIK
- 0001574579
No open-market purchases or sales filed in the past year.
Current role at each company
- XENE Xenon Pharmaceuticals Inc.Directoras of Sep 3, 2026
- ADVM Adverum Biotechnologies, Inc.Directoras of Dec 10, 2025
- SLRN ACELYRIN, Inc.Directoras of May 23, 2025
- GBT Global Blood Therapeutics, Inc.Directoras of Oct 6, 2022
- PTCT PTC Therapeutics, Inc.Directoras of Jun 10, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Svoronos Dawn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XENE Xenon Pharmaceuticals Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2023 (view filing) | Aug 24 | Same day | Svoronos DawnDirector | SSale | −25.0K | $38.70 | −$967.5K | −50.0%25.0K after |
SLRN ACELYRIN, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2023 (view filing) | May 9 | 2 days | Svoronos DawnDirector | PPurchase | +15.0K | $18.00 | +$270.0K | New position15.0K after |
GBT Global Blood Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2022 (view filing) | Jun 21 | 1 day | Svoronos DawnDirector | SSale | −1.91K | $27.24 | −$52.0K | −26.2%5.38K after |
PTCT PTC Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2022 (view filing) | Jun 9 | 1 day | Svoronos DawnDirector | SSale | −738 | $27.20 | −$20.1K | −2.5%29.0K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Svoronos DawnDirector | SSale | −510 | $38.53 | −$19.7K | −1.9%26.6K after |
ADVM Adverum Biotechnologies, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2022 (view filing) | May 16 | 2 days | Svoronos DawnDirector | PPurchase | +30.0K | $0.85 | +$25.5K | +150.0%50.0K after |